II
HZNP

Inspire Investing’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Inspire Investing’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,155
Closed -$365K – 835
2023
Q3 		$365K Buy
+3,155
New +$339K 0.05% 326
2023
Q2 		– Sell
-3,429
Closed -$374K – 833
2023
Q1 		$374K Buy
3,429
+428
+14% +$47.3K 0.05% 328
2022
Q4 		$342K Sell
3,001
-1,707
-36% -$142K 0.04% 289
2022
Q3 		$291K Buy
+4,708
New +$329K 0.04% 276
2022
Q2 		– Sell
-10,921
Closed -$1.15M – 806
2022
Q1 		$1.15M Sell
10,921
-489
-4% -$47.7K 0.13% 149
2021
Q4 		$1.23M Sell
11,410
-2,612
-19% -$285K 0.14% 143
2021
Q3 		$1.54M Buy
14,022
+4,674
+50% +$485K 0.19% 128
2021
Q2 		$875K Buy
9,348
+2,880
+45% +$265K 0.12% 204
2021
Q1 		$595K Buy
6,468
+1,463
+29% +$123K 0.09% 224
2020
Q4 		$366K Buy
+5,005
New +$372K 0.08% 339
2018
Q1 		– Sell
-3,794
Closed -$55K – 864
2017
Q4 		$55K Buy
+3,794
New +$53.3K 0.05% 655

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Inspire Investing's HZNP Position: Q4 2023 in Review

Inspire Investing sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,155 shares — an estimated $365K sold.

Inspire Investing first reported a position in HZNP in Q4 2017 and held it in 11 quarters. The position peaked at $1.54M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Inspire Investing reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Inspire Investing sold 3,155 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $365K.
  • Inspire Investing first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2017 and held it in 11 quarters.
  • Inspire Investing's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.54M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Inspire Investing's 13F filing for Q4 2023, filed 12 Feb 2024.